A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients

BACKGROUND: Myocardial infarction is the main mortality cause in patients with type 2 diabetes (T2DM). Endothelial dysfunction due to reduced bioavailability of nitric oxide (NO) is an early step of atherogenesis. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthesis, and it...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Mannino, Gaia Chiara, Pezzilli, Serena, Averta, Carolina, Fuoco, Anastasia, Spiga, Rosangela, Mancuso, Elettra, Di Fatta, Concetta, Perticone, Francesco, Prudente, Sabrina, Trischitta, Vincenzo, Andreozzi, Francesco, Sesti, Giorgio
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693196/
https://ncbi.nlm.nih.gov/pubmed/31409409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0906-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars